Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Biology & Therapy|March 10, 2017
Breast carcinoma associated with prolactinoma: A case reportYurong Zheng, Wenju Mo, Yang Yu, et al.
Clinical Medicine Insights. Oncology|September 25, 2023
The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 PatientsYuqin Ding, Kaijing Ding, Xiangming He, et al.
Frontiers in Oncology|September 14, 2020
Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer PatientsShujun Chen, Zhenyu Shu, Yongfeng Li, et al.
Cancer Biology & Therapy|May 19, 2020
The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experienceYurong Zheng, Xiaowen Ding, Dehong Zou, et al.
Oncology Letters|December 7, 2019
Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in ChinaYuqin Ding, Kaijing Ding, Kun Yu, et al.
Oncotarget|September 24, 2017
Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancerXianfeng Ding, Yuhan Zhang, Hongjian Yang, et al.
Oncology Research and Treatment|June 11, 2023
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialYuqin Ding, Wenju Mo, Xiaohong Xie, et al.
Plos One|April 17, 2020
Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancerYuqin Ding, Kaijing Ding, Hongdan Qian, et al.
Pageof 2